S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, open-label, phase III trial of S-1 plus cisplatin (3 weekly)
versus S-1 plus oxaliplatin chemotherapy for the first-line treatment of advanced gastric
cancer